Table 3 |
||||||||
|
Percentage of BM cells from AML patients recognized by peptides not binding to normal BM cells in a cytochemistry assay. |
||||||||
| Patient Number |
HP-A2 |
HP-A2A |
HP-G5 |
HP-G7 |
HP-D2 |
HP-B6 |
HP-B4 |
HP-A6 |
|
|
||||||||
| 15492 |
29 |
21 |
18 |
29 |
7 |
10 |
38 |
14 |
| 15480 |
36 |
ND |
ND |
31 |
ND |
23 |
ND |
ND |
| 17026 |
44 |
ND |
ND |
0 |
0 |
34 |
0 |
ND |
| 17648 |
32 |
40 |
31 |
44 |
50 |
52 |
19 |
21 |
| 16313 |
55 |
40 |
ND |
54 |
48 |
56 |
25 |
31 |
| 16352 |
76 |
60 |
63 |
0 |
77 |
85 |
59 |
62 |
| 16278 |
22 |
30 |
25 |
0 |
22 |
41 |
24 |
22 |
| 15727 |
80 |
72 |
51 |
74 |
82 |
87 |
27 |
17 |
| 1340 |
32 |
21 |
34 |
45 |
46 |
90 |
31 |
27 |
Galili et al. Journal of Hematology & Oncology 2008 1:8 doi:10.1186/1756-8722-1-8 |
||||||||
